Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression

Systemic corticosteroids increase the risk of diabetes, but what about in patients who take high-dose inhaled corticosteroids? How do we best manage the risk-benefit equation in patients with chronic obstructive pulmonary disease (or COPD)? Dr. Christopher Slatore, assistant professor in the division of pulmonary and critical care medicine, Portland VA Medical Center / Oregon Health and Sciences University, in Portland, Oregon, discusses the association between inhaled corticosteroid use and serum glucose concentration. Dr. Mary Leuchars hosts.